Virtu Financial’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Virtu Financial’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17,762	Closed	-$60K	–	2219
2018 Q3	$60K	Sell	17,762 -8,988	-34%	-$32.4K	﹤0.01%	1278
2018 Q2	$101K	Sell	26,750 -13,957	-34%	-$68K	0.01%	1646
2018 Q1	$166K	Buy	+40,707	New	+$190K	0.01%	1435
2017 Q4	–	Sell	-20,473	Closed	-$145K	–	3329
2017 Q3	$145K	Buy	+20,473	New	+$147K	0.01%	1976

Virtu Financial's KERX Position: Q4 2018 in Review

Virtu Financial sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 17,762 shares — an estimated $60K sold.

Virtu Financial first reported a position in KERX in Q3 2017 and held it in 4 quarters. The position peaked at $166K in Q1 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Virtu Financial reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Virtu Financial sold 17,762 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $60K.
Virtu Financial first reported a position in Keryx Biopharmaceuticals Inc in Q3 2017 and held it in 4 quarters.
Virtu Financial's Keryx Biopharmaceuticals Inc position peaked at $166K in Q1 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Virtu Financial's 13F filing for Q4 2018, filed 16 Jan 2019.